Skip to main content

Animations

MJFF Publications

5981 - 5990 of 6324 Results
Title
Year
  • Year
  • 2016
  • 2021
  • 2016
  • 2022
  • 2023
  • 2020
  • 2022
  • 2024
  • 2014
  • 2018
  • Summary Details
    OPEN
    Title: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020
    Citation Count: 93
  • Summary Details
    OPEN
    Title: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8
    Citation Count: 185
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29128
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/cells12030343
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25687
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29205
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stress
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1418896111
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.5539
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.